Innovative Stem Cell Therapy Developed for Parkinson's Disease

Chinese medical experts have developed an ultra-efficient stem cell therapy for Parkinson's disease, which is a movement disorder caused by the brain's failure to produce enough dopamine due to neuron impairment.

The team, led by neurology specialist Shi Jiong at the First Affiliated Hospital of the University of Science and Technology of China in Hefei, achieved over 80 percent efficiency in differentiating stem cells into functional cells, surpassing the international average of around 50 percent.

Since mid-2023, the team has been conducting a Phase I clinical trial with six patients, all of whom have shown rapid improvement in symptoms, including one participant, a 37-year-old woman surnamed Li, who experienced significant recovery and returned to normal life just three months post-treatment, highlighting the potential mental health benefits of this innovative approach.